KKR Considers Selling Stake In India’s $3 Billion JB Pharma, Sources Say
4 weeks ago•Bloomberg Quint
JB Chemicals Q3 Results Review - Domestic Business, CMO To Drive Future Growth: Nirmal Bang
1 month ago•Bloomberg Quint
JB Chemicals & Pharma - On M&A Spree To Diversify India Base: ICICI Securities
3 months ago•Bloomberg Quint
India Pharma - IPM Growth On Moderate Uptrend In September: Motilal Oswal
5 months ago•Bloomberg Quint
4+1 stocks that Dipan Mehta would keep in his 5-year-plus basket
7 months ago•Economic Times
JB Chemicals gets USFDA nod to market generic medication
7 months ago•Economic Times
JB Chemicals scales 52-week high on 35% surge in Q1 net profit
7 months ago•Moneycontrol